U.S. markets closed

Insperity, Inc. (NSP)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
92.10-2.27 (-2.41%)
At close: 4:00PM EDT
Sign in to post a message.
  • R
    Great News from NSP

    Insperity declares $0.45/share quarterly dividend (that's a 12.5% increase from prior dividend of $0.40)

    Forward yield 1.98%

    Payable June 24 for shareholders of Record Date of June 10. That makes the Ex-Dividend date June 9

    Good Luck to all NSP Investors.
  • R
    Fantastic Q1 Earning Report (especially since analysts had expected a sizable decline to Revenue and EPS)

    Q1 Non-GAAP EPS of $1.82 beats by $0.26

    GAAP EPS of $1.59 beats by $0.20

    Revenue of $1.29B (+4.9% Y/Y) beats by $90M

    In normal times, I'd expect some good upward movement tomorrow in the share price, but lately, it seems good earning reports are met with short term selloffs (for some unknown reason).

    Good Luck to all NSP Investors.
  • F
    Now is not the time to be a hero and catch a falling knife. Volume indicates the conviction behind a stock price move, and in this case, the stock went down huge on 8 time higher average daily volume. Institutional investors are voting with their feet......step in front of them and you will get trampled. Closed on lows of day, selling is nowhere near done.
  • F
    Employment report showing slowing job growth which isn't so good for these type of stocks.......but the earnings call kind of telegraphed this and thag is partly why the stock price took a hit. Still wouldn't buy yet because the trade war might just cause a recession.
  • g
    Last qtr NSP missed with $0.63 cents vs expectations of $1.10. Not only did they missed but they lowered guidance from .$0.81 to $0.50-$0.61 a 25% to 37% lowering. I think the market expected NSP to significantly beat this qtr with the guidance so low. Hence, we're seeing the disappointment. Looking to sell 60 strike puts once the down volume fades. Clearly, this company needs better leadership.
  • J
    Joe T
    if reinsurance costs are not going to affect their bottom line much as stated in the call, why the heck wouldn't they have had that previously to prevent excessive claims. seems like upper management missed the mark here in a big way.
  • R
    I don't think it was a bad quarter or year for $NSP, but the company took a big hit today when they announced they lost a large client....the below quote is pulled directly from the $NSP transcript:

    "The one exception in this year-end transition is the unexpected loss of our largest account we've ever had in our Enterprise segment that paid 6,800 worksite employees in December. We expected this account to renew for 2021. However, we were notified in mid-November, they were taking the HR function back in-house."

    I would think it will take some time for $NSP to make up for this loss
  • J
    $VERY.CN conversation
    Also $NSP only $0.06 just signed a deal with Sysvo (biggest food distributor in Canada) for plant based foods. Going to be over $0.10 +
  • J
    The trend tell you all you need to know. Recovery is far away, and small-medium size businesses will be the first to vanish, or substantially erode. Regardless of government infusion, businesses will attempt to remain in business - employment/payroll/benefits, etc will be the last things of consideration. Not going to be a pretty sunset.
  • D

    1) P/S of 0.66 much less than PAYX ( 5.1) and other HR companies
    2) P/E oof 12 much less than PAYX ( 23) and other HR companies
    3) Virtually zero debt
    4) PEG of 1.2 much less than PAYX ( 3) and other HR companies
    5) Market cap 2.6B much less than PAYX ( 27B) and other HR companies
    6) Hedge funds crashed the price by 25% to accumulate this cheap NSP
    7) NSP beat both earning and revenues .
    8) CEO says they have a plan to improve results in next quarters
    9) 25% haircut is not justified for slight lower guidance
  • A
    HOUSTON--(BUSINESS WIRE)--February 20, 2020--

    Insperity, Inc. (NYSE: NSP), a leading provider of human resources and business performance solutions for America's best businesses, today announced that its board of directors has approved a 33% increase in its quarterly regular cash dividend from $0.30 to $0.40 per share. The cash dividend will be paid on March 19, 2020 to all stockholders of record as of March 5, 2020.

    Insperity's board of directors also authorized an expansion of its stock repurchase program by an additional 1 million shares, and as a result will have approximately 1.4 million shares available for repurchase. Purchases may be made from time to time in the open market or in privately negotiated transactions. The company may also adopt Rule 10b5-1 prearranged stock trading plans designed to facilitate Insperity's repurchase of its common stock during times it would not otherwise be in the open market due to self-imposed trading blackout periods or possible possession of material nonpublic information.
  • M
    This is definitely a long-term play if you buy in now. Will see $100, minimum, one year from now.
  • J
    A PE of 43+ and still buying???
  • J
    Economists project dismal recovery and the worst economy in seven decades lies ahead. Clients will be smaller (fewer employees) with reduced revenue & profit. Will they continue to utilize expensive payroll processing for a benefits offering that will skyrocket at renewals? I think not. NSP is very expensive and as the economy/business struggles in coming years, I think NSP client base and operating results will suffer. I don't always agree with economists and their projections, but in this case I think they will be frightenly accurate.
  • C
    Captain Hairpiece
    Timber!!!! wow almost bought way higher. Now waiting.
  • J
    $VEGA.CN conversation
    Naturally Splendid $NSP & Plant & Co $VEGN moving!

    Both new Plant Based company’s going to the moon!
  • R
    depends on the eps trend...... This could be a long hold.
  • S
    Sluggo Bear
    It blows me away that an SP can drop 30% because of one quarter's anomalous results – results that they can’t predict and have no control over. The miss was due primarily to a large uptick in the number of "jumbo" ($250K+) medical events – they reported cardiac and cancer events. I know what just one medical situation can do to the finances of even a big company. One of my 25 direct reports (in a company of 7000 employees) had a premature birth at 22 weeks. It came to over $1M charges.
  • K
    in at 69
  • O
    I bought some just to dabble. Should it pay off?